Veurink Marieke, Koster Marlies, Berg Lolkje T W de Jong-van den
Department of Social Pharmacy, Pharmacoepidemiology and Pharmacotherapy, Groningen University Institute of Drug Exploration (GUIDE), Ant. Deusinglaan 1, 9713, AV Groningen, The Netherlands.
Pharm World Sci. 2005 Jun;27(3):139-43. doi: 10.1007/s11096-005-3663-z.
Since the 1940s, diaethylstilbestrol (DES) has been used by millions of pregnant women to prevent miscarriages and many other disorders in pregnancy. In 1971, it became clear that this apparently innocent treatment proved to be a time bomb for the infants exposed to DES during the first trimester of pregnancy. DES is now associated with an increased risk of breast cancer, clear cell adenocarcinoma (CCAC) of the vagina and cervix, and reproductive anomalies. This article summarises the potential long-term health implications of DES on the mother, DES daughters and DES sons, and the possible side effects on the third generation. Health care professionals have to know the history of DES to prevent future disasters with drugs prescribed.
自20世纪40年代以来,数百万孕妇使用己烯雌酚(DES)来预防流产及孕期的许多其他疾病。1971年,人们清楚地认识到,这种看似无害的治疗方法对孕期头三个月接触DES的婴儿来说,实则是一颗定时炸弹。如今,DES与乳腺癌、阴道和宫颈透明细胞腺癌(CCAC)以及生殖器官异常的风险增加有关。本文总结了DES对母亲、DES女儿和DES儿子潜在的长期健康影响,以及对第三代可能产生的副作用。医疗保健专业人员必须了解DES的历史,以防止因所开药物引发未来的灾难。